ESMO Preceptorship on Metastatic Bladder and Kidney Cancer 2024: Lugano

Start

Wed, 3 Apr 2024, 09:00

End

Thu, 4 Apr 2024, 06:00

WebSite

https://iii.hm/lugano2024

Venue:

Find ESMO On Social Media

Exhibit

Symposia

Workshops

Organiser

Sponsor

Learning objectives

To learn about fundamentals of molecular pathology and diagnosis as contributing factors to heterogeneity in bladder and kidney cancer
To understand essentials in the assessment and multidisciplinary treatment of bladder and kidney cancer
To learn about advances in treatment and novel targets in bladder and kidney cancer

Health and Safety Policy

It is each participant’s responsibility to check and comply with the latest health and travel regulations to ensure a smooth and safe journey from the Country of origin to the event venue, and back.

During the event, ESMO will apply health and safety protocols according to the latest local authority guidelines and regulations.

In general, ESMO recommends:

To apply health precautions and measures according to formal guidance and personal medical history
To stay up to date with the vaccination status
To perform a Rapid Antigen Test and wear a mask in case of symptoms

Hand sanitisers will be available throughout the venue; the use of mask is at own discretion in the absence of symptoms.

Any changes to the ESMO health and safety protocols will be communicated on this webpage.

Accreditation

The programme of this event will be accredited with ESMO-MORA category 1 points. Recertification is necessary for medical oncologists to remain professionally certified by ESMO. Recertification guarantees that a certified medical oncologist has continued to update her/his knowledge and continues to possess the necessary skills and standards for the practice of medical oncology. For further details, please refer to ESMO-MORA Recertification Process & Requirements.